The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Rifabutin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rifabutin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rifabutin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rifabutin in Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rifabutin include RedHill Biopharma Ltd., Pfizer, Lupin, Olon, Janssen Pharma, JINLAN Pharm-Drugs Technology Co., Ltd., NOVITIUM PHARMA, Guangzhou Tosun Pharmaceutical and Chongqing Huapont Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rifabutin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifabutin.
Report Scope
The Rifabutin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rifabutin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rifabutin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RedHill Biopharma Ltd.
Pfizer
Lupin
Olon
Janssen Pharma
JINLAN Pharm-Drugs Technology Co., Ltd.
NOVITIUM PHARMA
Guangzhou Tosun Pharmaceutical
Chongqing Huapont Pharmaceutical
5M Biotech India
SR Chemical And Pharmaceuticals
LOK-BETA Pharmaceuticals (I) Pvt Ltd
HANGZHOU HEXO CHEMTECH CO., LTD
Segment by Type
25 mg
100 mg
150 mg
Segment by Application
Pharmacy
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rifabutin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Rifabutin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rifabutin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rifabutin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rifabutin in Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rifabutin include RedHill Biopharma Ltd., Pfizer, Lupin, Olon, Janssen Pharma, JINLAN Pharm-Drugs Technology Co., Ltd., NOVITIUM PHARMA, Guangzhou Tosun Pharmaceutical and Chongqing Huapont Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rifabutin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifabutin.
Report Scope
The Rifabutin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rifabutin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rifabutin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RedHill Biopharma Ltd.
Pfizer
Lupin
Olon
Janssen Pharma
JINLAN Pharm-Drugs Technology Co., Ltd.
NOVITIUM PHARMA
Guangzhou Tosun Pharmaceutical
Chongqing Huapont Pharmaceutical
5M Biotech India
SR Chemical And Pharmaceuticals
LOK-BETA Pharmaceuticals (I) Pvt Ltd
HANGZHOU HEXO CHEMTECH CO., LTD
Segment by Type
25 mg
100 mg
150 mg
Segment by Application
Pharmacy
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rifabutin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rifabutin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 25 mg
1.2.3 100 mg
1.2.4 150 mg
1.3 Market by Application
1.3.1 Global Rifabutin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rifabutin Market Perspective (2019-2030)
2.2 Rifabutin Growth Trends by Region
2.2.1 Global Rifabutin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rifabutin Historic Market Size by Region (2019-2024)
2.2.3 Rifabutin Forecasted Market Size by Region (2025-2030)
2.3 Rifabutin Market Dynamics
2.3.1 Rifabutin Industry Trends
2.3.2 Rifabutin Market Drivers
2.3.3 Rifabutin Market Challenges
2.3.4 Rifabutin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rifabutin Players by Revenue
3.1.1 Global Top Rifabutin Players by Revenue (2019-2024)
3.1.2 Global Rifabutin Revenue Market Share by Players (2019-2024)
3.2 Global Rifabutin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rifabutin Revenue
3.4 Global Rifabutin Market Concentration Ratio
3.4.1 Global Rifabutin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rifabutin Revenue in 2023
3.5 Rifabutin Key Players Head office and Area Served
3.6 Key Players Rifabutin Product Solution and Service
3.7 Date of Enter into Rifabutin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rifabutin Breakdown Data by Type
4.1 Global Rifabutin Historic Market Size by Type (2019-2024)
4.2 Global Rifabutin Forecasted Market Size by Type (2025-2030)
5 Rifabutin Breakdown Data by Application
5.1 Global Rifabutin Historic Market Size by Application (2019-2024)
5.2 Global Rifabutin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rifabutin Market Size (2019-2030)
6.2 North America Rifabutin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rifabutin Market Size by Country (2019-2024)
6.4 North America Rifabutin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rifabutin Market Size (2019-2030)
7.2 Europe Rifabutin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rifabutin Market Size by Country (2019-2024)
7.4 Europe Rifabutin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rifabutin Market Size (2019-2030)
8.2 Asia-Pacific Rifabutin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rifabutin Market Size by Region (2019-2024)
8.4 Asia-Pacific Rifabutin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rifabutin Market Size (2019-2030)
9.2 Latin America Rifabutin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rifabutin Market Size by Country (2019-2024)
9.4 Latin America Rifabutin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rifabutin Market Size (2019-2030)
10.2 Middle East & Africa Rifabutin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rifabutin Market Size by Country (2019-2024)
10.4 Middle East & Africa Rifabutin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RedHill Biopharma Ltd.
11.1.1 RedHill Biopharma Ltd. Company Detail
11.1.2 RedHill Biopharma Ltd. Business Overview
11.1.3 RedHill Biopharma Ltd. Rifabutin Introduction
11.1.4 RedHill Biopharma Ltd. Revenue in Rifabutin Business (2019-2024)
11.1.5 RedHill Biopharma Ltd. Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Rifabutin Introduction
11.2.4 Pfizer Revenue in Rifabutin Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Lupin
11.3.1 Lupin Company Detail
11.3.2 Lupin Business Overview
11.3.3 Lupin Rifabutin Introduction
11.3.4 Lupin Revenue in Rifabutin Business (2019-2024)
11.3.5 Lupin Recent Development
11.4 Olon
11.4.1 Olon Company Detail
11.4.2 Olon Business Overview
11.4.3 Olon Rifabutin Introduction
11.4.4 Olon Revenue in Rifabutin Business (2019-2024)
11.4.5 Olon Recent Development
11.5 Janssen Pharma
11.5.1 Janssen Pharma Company Detail
11.5.2 Janssen Pharma Business Overview
11.5.3 Janssen Pharma Rifabutin Introduction
11.5.4 Janssen Pharma Revenue in Rifabutin Business (2019-2024)
11.5.5 Janssen Pharma Recent Development
11.6 JINLAN Pharm-Drugs Technology Co., Ltd.
11.6.1 JINLAN Pharm-Drugs Technology Co., Ltd. Company Detail
11.6.2 JINLAN Pharm-Drugs Technology Co., Ltd. Business Overview
11.6.3 JINLAN Pharm-Drugs Technology Co., Ltd. Rifabutin Introduction
11.6.4 JINLAN Pharm-Drugs Technology Co., Ltd. Revenue in Rifabutin Business (2019-2024)
11.6.5 JINLAN Pharm-Drugs Technology Co., Ltd. Recent Development
11.7 NOVITIUM PHARMA
11.7.1 NOVITIUM PHARMA Company Detail
11.7.2 NOVITIUM PHARMA Business Overview
11.7.3 NOVITIUM PHARMA Rifabutin Introduction
11.7.4 NOVITIUM PHARMA Revenue in Rifabutin Business (2019-2024)
11.7.5 NOVITIUM PHARMA Recent Development
11.8 Guangzhou Tosun Pharmaceutical
11.8.1 Guangzhou Tosun Pharmaceutical Company Detail
11.8.2 Guangzhou Tosun Pharmaceutical Business Overview
11.8.3 Guangzhou Tosun Pharmaceutical Rifabutin Introduction
11.8.4 Guangzhou Tosun Pharmaceutical Revenue in Rifabutin Business (2019-2024)
11.8.5 Guangzhou Tosun Pharmaceutical Recent Development
11.9 Chongqing Huapont Pharmaceutical
11.9.1 Chongqing Huapont Pharmaceutical Company Detail
11.9.2 Chongqing Huapont Pharmaceutical Business Overview
11.9.3 Chongqing Huapont Pharmaceutical Rifabutin Introduction
11.9.4 Chongqing Huapont Pharmaceutical Revenue in Rifabutin Business (2019-2024)
11.9.5 Chongqing Huapont Pharmaceutical Recent Development
11.10 5M Biotech India
11.10.1 5M Biotech India Company Detail
11.10.2 5M Biotech India Business Overview
11.10.3 5M Biotech India Rifabutin Introduction
11.10.4 5M Biotech India Revenue in Rifabutin Business (2019-2024)
11.10.5 5M Biotech India Recent Development
11.11 SR Chemical And Pharmaceuticals
11.11.1 SR Chemical And Pharmaceuticals Company Detail
11.11.2 SR Chemical And Pharmaceuticals Business Overview
11.11.3 SR Chemical And Pharmaceuticals Rifabutin Introduction
11.11.4 SR Chemical And Pharmaceuticals Revenue in Rifabutin Business (2019-2024)
11.11.5 SR Chemical And Pharmaceuticals Recent Development
11.12 LOK-BETA Pharmaceuticals (I) Pvt Ltd
11.12.1 LOK-BETA Pharmaceuticals (I) Pvt Ltd Company Detail
11.12.2 LOK-BETA Pharmaceuticals (I) Pvt Ltd Business Overview
11.12.3 LOK-BETA Pharmaceuticals (I) Pvt Ltd Rifabutin Introduction
11.12.4 LOK-BETA Pharmaceuticals (I) Pvt Ltd Revenue in Rifabutin Business (2019-2024)
11.12.5 LOK-BETA Pharmaceuticals (I) Pvt Ltd Recent Development
11.13 HANGZHOU HEXO CHEMTECH CO., LTD
11.13.1 HANGZHOU HEXO CHEMTECH CO., LTD Company Detail
11.13.2 HANGZHOU HEXO CHEMTECH CO., LTD Business Overview
11.13.3 HANGZHOU HEXO CHEMTECH CO., LTD Rifabutin Introduction
11.13.4 HANGZHOU HEXO CHEMTECH CO., LTD Revenue in Rifabutin Business (2019-2024)
11.13.5 HANGZHOU HEXO CHEMTECH CO., LTD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Rifabutin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 25 mg
Table 3. Key Players of 100 mg
Table 4. Key Players of 150 mg
Table 5. Global Rifabutin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Rifabutin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Rifabutin Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Rifabutin Market Share by Region (2019-2024)
Table 9. Global Rifabutin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Rifabutin Market Share by Region (2025-2030)
Table 11. Rifabutin Market Trends
Table 12. Rifabutin Market Drivers
Table 13. Rifabutin Market Challenges
Table 14. Rifabutin Market Restraints
Table 15. Global Rifabutin Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Rifabutin Market Share by Players (2019-2024)
Table 17. Global Top Rifabutin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifabutin as of 2023)
Table 18. Ranking of Global Top Rifabutin Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Rifabutin Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rifabutin Product Solution and Service
Table 22. Date of Enter into Rifabutin Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rifabutin Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Rifabutin Revenue Market Share by Type (2019-2024)
Table 26. Global Rifabutin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Rifabutin Revenue Market Share by Type (2025-2030)
Table 28. Global Rifabutin Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Rifabutin Revenue Market Share by Application (2019-2024)
Table 30. Global Rifabutin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Rifabutin Revenue Market Share by Application (2025-2030)
Table 32. North America Rifabutin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Rifabutin Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Rifabutin Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Rifabutin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Rifabutin Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Rifabutin Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Rifabutin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Rifabutin Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Rifabutin Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Rifabutin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Rifabutin Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Rifabutin Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Rifabutin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Rifabutin Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Rifabutin Market Size by Country (2025-2030) & (US$ Million)
Table 47. RedHill Biopharma Ltd. Company Detail
Table 48. RedHill Biopharma Ltd. Business Overview
Table 49. RedHill Biopharma Ltd. Rifabutin Product
Table 50. RedHill Biopharma Ltd. Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 51. RedHill Biopharma Ltd. Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Rifabutin Product
Table 55. Pfizer Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Lupin Company Detail
Table 58. Lupin Business Overview
Table 59. Lupin Rifabutin Product
Table 60. Lupin Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 61. Lupin Recent Development
Table 62. Olon Company Detail
Table 63. Olon Business Overview
Table 64. Olon Rifabutin Product
Table 65. Olon Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 66. Olon Recent Development
Table 67. Janssen Pharma Company Detail
Table 68. Janssen Pharma Business Overview
Table 69. Janssen Pharma Rifabutin Product
Table 70. Janssen Pharma Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 71. Janssen Pharma Recent Development
Table 72. JINLAN Pharm-Drugs Technology Co., Ltd. Company Detail
Table 73. JINLAN Pharm-Drugs Technology Co., Ltd. Business Overview
Table 74. JINLAN Pharm-Drugs Technology Co., Ltd. Rifabutin Product
Table 75. JINLAN Pharm-Drugs Technology Co., Ltd. Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 76. JINLAN Pharm-Drugs Technology Co., Ltd. Recent Development
Table 77. NOVITIUM PHARMA Company Detail
Table 78. NOVITIUM PHARMA Business Overview
Table 79. NOVITIUM PHARMA Rifabutin Product
Table 80. NOVITIUM PHARMA Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 81. NOVITIUM PHARMA Recent Development
Table 82. Guangzhou Tosun Pharmaceutical Company Detail
Table 83. Guangzhou Tosun Pharmaceutical Business Overview
Table 84. Guangzhou Tosun Pharmaceutical Rifabutin Product
Table 85. Guangzhou Tosun Pharmaceutical Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 86. Guangzhou Tosun Pharmaceutical Recent Development
Table 87. Chongqing Huapont Pharmaceutical Company Detail
Table 88. Chongqing Huapont Pharmaceutical Business Overview
Table 89. Chongqing Huapont Pharmaceutical Rifabutin Product
Table 90. Chongqing Huapont Pharmaceutical Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 91. Chongqing Huapont Pharmaceutical Recent Development
Table 92. 5M Biotech India Company Detail
Table 93. 5M Biotech India Business Overview
Table 94. 5M Biotech India Rifabutin Product
Table 95. 5M Biotech India Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 96. 5M Biotech India Recent Development
Table 97. SR Chemical And Pharmaceuticals Company Detail
Table 98. SR Chemical And Pharmaceuticals Business Overview
Table 99. SR Chemical And Pharmaceuticals Rifabutin Product
Table 100. SR Chemical And Pharmaceuticals Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 101. SR Chemical And Pharmaceuticals Recent Development
Table 102. LOK-BETA Pharmaceuticals (I) Pvt Ltd Company Detail
Table 103. LOK-BETA Pharmaceuticals (I) Pvt Ltd Business Overview
Table 104. LOK-BETA Pharmaceuticals (I) Pvt Ltd Rifabutin Product
Table 105. LOK-BETA Pharmaceuticals (I) Pvt Ltd Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 106. LOK-BETA Pharmaceuticals (I) Pvt Ltd Recent Development
Table 107. HANGZHOU HEXO CHEMTECH CO., LTD Company Detail
Table 108. HANGZHOU HEXO CHEMTECH CO., LTD Business Overview
Table 109. HANGZHOU HEXO CHEMTECH CO., LTD Rifabutin Product
Table 110. HANGZHOU HEXO CHEMTECH CO., LTD Revenue in Rifabutin Business (2019-2024) & (US$ Million)
Table 111. HANGZHOU HEXO CHEMTECH CO., LTD Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rifabutin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rifabutin Market Share by Type: 2023 VS 2030
Figure 3. 25 mg Features
Figure 4. 100 mg Features
Figure 5. 150 mg Features
Figure 6. Global Rifabutin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Rifabutin Market Share by Application: 2023 VS 2030
Figure 8. Pharmacy Case Studies
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Rifabutin Report Years Considered
Figure 13. Global Rifabutin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Rifabutin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Rifabutin Market Share by Region: 2023 VS 2030
Figure 16. Global Rifabutin Market Share by Players in 2023
Figure 17. Global Top Rifabutin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifabutin as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Rifabutin Revenue in 2023
Figure 19. North America Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Rifabutin Market Share by Country (2019-2030)
Figure 21. United States Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Rifabutin Market Share by Country (2019-2030)
Figure 25. Germany Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Rifabutin Market Share by Region (2019-2030)
Figure 33. China Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Rifabutin Market Share by Country (2019-2030)
Figure 41. Mexico Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Rifabutin Market Share by Country (2019-2030)
Figure 45. Turkey Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Rifabutin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. RedHill Biopharma Ltd. Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 49. Lupin Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 50. Olon Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 51. Janssen Pharma Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 52. JINLAN Pharm-Drugs Technology Co., Ltd. Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 53. NOVITIUM PHARMA Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 54. Guangzhou Tosun Pharmaceutical Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 55. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 56. 5M Biotech India Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 57. SR Chemical And Pharmaceuticals Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 58. LOK-BETA Pharmaceuticals (I) Pvt Ltd Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 59. HANGZHOU HEXO CHEMTECH CO., LTD Revenue Growth Rate in Rifabutin Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
